A new 'on' signal for inflammation

May 14, 2013

(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause trouble in conditions including rheumatoid arthritis, inflammatory bowel disease and a potentially fatal immune reaction to infection called sepsis.

A new study involving UCD researchers has discovered a signal that appears to trigger inflammation when the threat of a looms, and the experiments have also been able to block the signal in lab models, pointing to possible new approaches to treating .

The study, which was published in Nature and led by Trinity College Dublin, found that in the presence of a potential bacterial threat, called change how they burn energy. This switch in burning eventually leads to the build-up of a molecule called succinate in the cells, and this in turn triggers a chain of biochemical events that encourage inflammation.

One link in that chain is a molecule called hypoxia-induced factor 1a (HIF-1a). HIF-1a is best known for its role in helping you adapt to conditions of low oxygen, such as when you climb a high mountain and the ambient dip, explains Conway Fellow, Professor Cormac Taylor from UCD School of Medicine & Medical Science.

"When you go to high altitude, this factor gets expressed in cells and that helps to increase the number of red blood cells in your blood, so you can adapt to the lower oxygen," he explains.

But that's not the only place that HIF-1a has a job to do. "At time of stress including inflammation you also experience an activation of this HIF pathway," says Prof Taylor. "And previous work in our lab has looked at this in models of ."

In the new study, which was led by Prof Luke O'Neill at Trinity, Prof Taylor and Research Fellow Dr Eoin Cummins from UCD helped to work out that in macrophages sensing a bacterial threat, the build-up of succinate seems to 'tell' HIF-1a to switch on an inflammatory gene.

"In this case, HIF drives a gene called interleukin-1, which is a potent pro-inflammatory gene," explains Prof Taylor. "And that will contribute to the inflammatory process."

The new study makes an important link between energy burning processes in the immune system and an 'on' signal for inflammation, according to Prof Taylor. The research also showed that a drug usually used for epilepsy was able to tone down this succinate/HIf-1a pathway in a lab model of sepsis, and this could point to new approaches to intervening when inflammation is running out of control, he adds.

"It's a big emerging area, the links between metabolism, or energy burning, and inflammation in disease," says Prof Taylor. "And in the future we could be targeting these metabolic pathways for beneficial purposes in inflammation."

Explore further: Illuminating cross talk between signalling factors

Related Stories

Illuminating cross talk between signalling factors

November 22, 2011
(Medical Xpress) -- Hypoxia and inflammation are environmental features occuring simultaneously in a variety of diseases such as growing tumours and critically inflamed tissues. UCD scientists investigating the relative contributions ...

Lack of oxygen in cancer cells leads to growth and metastasis

September 13, 2012
(Medical Xpress)—It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked ...

Researchers reveal that immune system like a turbo-charged hybrid car

April 4, 2013
(Medical Xpress)—Trinity College Dublin scientists have made a significant breakthrough in understanding the immune system that could lead to new treatments for diseases such as sepsis and Type 2 diabetes. A team led by ...

Researchers link stress and pancreatic cancer in new paper

February 15, 2013
Pancreatic cancer is a deadly disease with increased incidences in the recent years. According to NDSU researchers, epidemiological data show chronic stress in a negative social and psychological state such as depression ...

Key pathway to stop dangerous, out-of-control inflammation discovered

April 9, 2013
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.

Recommended for you

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Researchers reveal potential target for the treatment of skin inflammation in eczema and psoriasis

May 22, 2017
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.